Cannabis Stock News- Investing in Cannabis and Hemp Stocks

https://www.investorideas.com/About/

Contact Investorideas.com

800-665-0411

Get more Cannabis Stock Investor Ideas – news , articles , podcasts and stock directories

Better Together: #Cannabis-Infused #Beer JV’s Ready Themselves for October Legalization (CSE: $SPR.C) (OTCQB: $SRUTF) (NYSE: $CGC) (TSXV: $BEER.V) (NYSE: $HEXO)

Better Together: #Cannabis-Infused #Beer JV’s Ready Themselves for October Legalization (CSE: $SPR.C) (OTCQB: $SRUTF) (NYSE: $CGC) (TSXV: $BEER.V) (NYSE: $HEXO)

Point Roberts WA, Delta, BC – April 30, 2019 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at cannabis-infused beer JV’s and distribution partnerships as they ready themselves for the upcoming Canadian consumables market, as regulations are expected to permit this October.

Read this in full at https://www.investorideas.com/news/2019/cannabis/04304Stocks-Beer.asp

Recently one of the largest cannabis beverage partnerships involving Canopy Growth Corp. (NYSE:CGC) (TSX: WEED) and Constellation Brands, Inc. announced that they have agreed to make some changes to various warrants and rights.

The new agreement to change some of the warrants and rights that influence their partnership is believed to have been influenced by Canopy’s plans to acquire Acreage Holdings Inc. Another key factor that influenced the decision by Constellation Brands and Canopy Growth to review the warrants and rights is the chance of cannabis legalization by the federal government.

The attention surrounding cannabis-infused beers is bringing in new players such as Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF), and Moosehead Breweries Limited, who just announced that they have entered into a definitive agreement to form an exclusive joint venture to develop, produce, and market cannabis-infused beverages in Canada using Sproutly’s acquired proprietary, naturally produced water-soluble cannabinoids known as Infuz2O.

Moosehead, the oldest and largest Independent Beer Company in Canada, brings over 152 years of beverage experience in building and operating adult beverage businesses in Canada, an established national supply chain and distribution capabilities in all provinces with a large sales and marketing team and the Oland family’s proven ability in building and marketing industry leading adult beverage brands such as Moosehead and licensed and supporting brands such as Alexander Keith’s, Angry Orchard and Twisted Tea.

Sproutly’s Infuz2O can deliver the cannabis effect within 5 minutes and last up to 90 minutes, providing a similar experience timeframe to beer, while also producing a clear cannabis beverage that is much easier and faster to formulate than many of its competitors who will be using emulsifiers, encapsulation or chemically modified techniques to strangely mirror solubility.

“With the anticipated legalization of edibles in Canada later this year, Moosehead has made the strategic decision to enter the cannabis beverage market. As one of the oldest brands in Canada and a leader in the beer category, we believe we are uniquely positioned to be a leader in the cannabis beverage category.” said Andrew Oland, Chief Executive Officer of Moosehead. “As a 152 year old company spanning six generations, we are very selective about new business opportunities. After a significant amount of due diligence on Sproutly’s APP technology and Infuz₂O water soluble cannabinoids vs other competitive technologies, we are excited to announce this joint venture. With their advanced technology and our long-standing product development experience, we expect to bring to Canadian consumers cannabis beverages that address the major issues currently limiting appeal of this category in other markets; a beverage that: 1) actually tastes good; and 2) provides an immediate and controllable cannabis experience lasting up to 90 minutes.”

“After careful analysis of the cannabis industry and the cannabis beverage opportunity in Canada, we believe that Moosehead and Sproutly together are well positioned to become a significant player in the category.” said Matthew Oland, incoming Chief Executive Officer of the Joint Venture. “The JV’s ability to leverage Moosehead’s rich history of building adult-beverage brands, and its established R&D and operational infrastructure, will enable the JV to bring great tasting cannabis beverages to Canadian consumers. The Infuz₂0 technology delivers a natural cannabis beverage experience, with an onset and offset time similar to traditional flower cannabis, without the need for chemical modification. We believe this will be a game changer for the sector.”

Lexaria Bioscience Corp., who develops and licenses DehydraTECH, a patented lipid nutrient infusion technology that improves taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins, NSAIDs, nicotine, and other molecules, has also been looking into the beverage sector for quite some time, having partnered with Hill Street Beverage Company Inc. (TSX-V:BEER) (OTC: HSEEF)

Hill Street CEO Terry Donnelly recently discussed the company’s first quarter which showed the company’s revenue was up 100 percent YOY and the company is tracking 35 percent annual revenue growth for 2019. Donnelly also discussed how Hill Street has used its line of non-alcoholic beer and wine to drive its brand recognition ahead of the legalization of infused beverages in the fall. Hill Street uses Lexaria’s DehydraTECH to create infused beverages which allows for 5 to 10 percent greater availability of THC and ensures consumers feel the beverage’s full effect in 15 minutes.

A sleeping giant in this same sector that is surrounded by market anticipation is Truss, the JV of Molson Coors Canada, the Canadian business unit of Molson Coors Brewing Company, and HEXO Corp. (NYSE: HEXO) (TSX: HEXO) who announced their partnership back in August 1, 2018, to develop non-alcoholic, cannabis-infused beverages for the Canadian market following legalization.

“With the backing of two partners with deep Canadian roots, proven success, and market-leading experience in the respective beverage and cannabis industries in Canada, Truss will hit the ground running,” said Brett Vye, Chief Executive Officer at Truss. “When consumable cannabis is legalized in Canada, Truss will be ready to make its mark as a responsible leader in providing high-quality beverages for the Canadian consumer. Why “Truss”? We are joining together the extensive experience and excellent practices of each partner to build a powerful foundation for the future.”

This combination of experienced beverage providers with cannabis technology companies allows for all of these companies to have the best of both worlds. As these JV’s ready themselves for October the only big question is what the finalized regulations will permit and how these companies may have to alter their approach to match them.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

Follow us on Cannabis Social Media

https://www.investorideas.com/Audio/Podcasts/2019/042919-StocksToWatch.mp3

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: this news article featuring Sproutly Inc (SPR) is a paid for news release on Investorideas.com – third party.

Contact management and IR of each company directly regarding specific questions.

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com

800-665-0411

Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories

Investorideas.com - Better Quality & Innovation Continue In CBD Pets Products Coming to Market (TSX: WEED) (NYSE: CGC) (OTC: LRSV) (OTC: MJNA) (TSXV: EAST)

Monday, April 29, 2019

Investorideas.com - Cannabis News: First Choom (CSE: CHOO; OTCQB: CHOOF) Branded Store to Open in Niagara Falls

Investorideas.com - Cannabis News: First Choom (CSE: CHOO; OTCQB: CHOOF) Branded Store to Open in Niagara Falls

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Cannabis Earnings News: Cannara Biotech (CSE: LOVE) Reports Q2 2019 Results

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $ZENA.V) (CSE: $HITI.C) (OTCQB: $HITIF)(TSXV: $KHRN.V) (OTCQB: $KHRNF)

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $ZENA.V) (CSE: $HITI.C) (OTCQB: $HITIF)(TSXV: $KHRN.V) (OTCQB: $KHRNF)

Delta, Kelowna, BC –April 29th, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcasts^CM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/04291ZENA-HITI-HITIF-KHRN-KHRNF.asp

Hear Investor ideas cannabis potcast on iTunes

Today’s podcast overview/transcript:

Good morning and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast begins with an introduction of myself, Taylor Van Zant the host of our “potcasts” and after that I focus on a few early announcements from a few interesting companies.

Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF), an integrated cannabis company with its core operations in Latin America, announced today that the Company has signed an LOI with Copservir Ltda., Colombia's largest pharmacy chain, to distribute Khiron's medical cannabis products across the country. The companies have agreed to initial discounting and commercial fees and will work towards establishing a definitive commercial contract and detailed distribution plan to begin sales in the second half of 2019.

As Colombia's largest pharmacy chain, Copservir Ltda., operates over 900 stores across 200 cities and municipalities with a traditional brick and mortar presence representing 75% of its CAD 500 Million / year sales. In addition, a growing virtual presence represents 25% of its sales with an annual growth rate of over 20%. The company combines its retail and virtual presence with a strong distribution and logistics platform with four distribution centres in the main cities of Colombia and a home delivery service in 120 cities. This makes the Colombian Government-administered company the largest by store-count pharmacy chain in the country.

On completion of the agreement, Khiron will have established a compliant and secure distribution platform for its medical products across Colombia, starting with its custom-made pharmacy compound strategy. Copservir's extensive brick-and-mortar presence, virtual channel and distribution capability will allow Khiron to offer patients across the country the option for pick-up or home delivery of their medical cannabis formulations. Coupled with Khiron's ongoing medical education platform to educate and engage doctors and physicians across the country, this distribution strategy will allow Khiron to reach more patients in a safe, compliant and innovative matter.

Alvaro Torres, Khiron CEO and Director commented, "The proposed agreement with Copservir Ltda. represents a significant development for Khiron, offering the opportunity to leverage our first mover advantage to distribute medical cannabis products across Colombia and service the more than 5 million potential patients in the country. We also view Copservir entering the medical cannabis market as a milestone validation of the market opportunity in Colombia. By offering a platform that makes it easier for patients to access their formulations in a compliant and safe manner, Khiron establishes a leadership position in the medical cannabis market in Colombia."

The companies will work towards establishing definite commercial and distribution agreements to begin sales in the second half of 2019.

High Tide Inc. (CSE:HITI) (OTCQB:HITIF), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, announced that on Friday, April 26, 2019 the Alcohol and Gaming Commission of Ontario ("AGCO") approved and issued a Retail Operator Licence to High Tide's counterparty Dana Michele Kendal for the Canna Cabana Toronto store. A Retail Store Authorization will also be required to be issued by the AGCO for the Winner to finalize the set-up of the Toronto Store. The Winner is aiming to open Canna Cabana Toronto on or before June 1, 2019.

The Toronto Store is expected to be highest profile Canna Cabana-branded location in Canada. "From originally being selected by the Winner to help establish the Toronto Store, to achieving this important milestone part-way through the process, we are growing very keen to open this shop near the intersection of Yonge Street and College Street," said Raj Grover, President and Chief Executive Officer of High Tide. "High Tide's best efforts are being put toward this project and we look forward to the privilege of the Toronto Store becoming a part of the surrounding community for the long term," added Mr. Grover. Prior to opening the Toronto Store, the AGCO will conduct a pre-opening inspection to ensure that the Winner is ready to sell cannabis products to the public in accordance with the regulations and standards for cannabis retail stores.

Zenabis Global Inc. (TSXV: ZENA) (OTC:ZBISF) announced that it has entered into a binding term sheet for a three-year supply arrangement with leading German pharmaceutical research company Farmako GmbH for: (1) the supply of biosynthetically produced pure CBD isolate oil (99.9%) from Farmako to Zenabis for sale in Canada; and (2) the supply of European Union Good Manufacturing Practices certified cannabis cultivated in Zenabis' indoor facilities in Canada for sale by Farmako to the German medical market.

Andrew Grieve, Chief Executive Officer of Zenabis, stated, "While Zenabis is committed to producing both hemp- and cannabis-derived CBD products, we are thrilled to have signed the very first commercial agreement globally of its kind for the purchase of biosynthetic cannabinoids. We are purchasing the CBD isolates from Farmako at an incredibly low cost, which will allow us to tap into the rapidly growing Canadian CBD market by supplying products that will be priced much more competitively than current market offerings. This partnership will also enable Zenabis to supply high-quality medical cannabis into Germany, one of the largest medical cannabis markets in the world, thereby establishing our position in the European cannabis market."

Farmako founder and chief executive officer, Niklas Kouparanis, said, "Signing the first deal in history to sell mass-produced CBD isolate created by biosynthesis to Zenabis is a significant milestone for both Farmako and for the global Cannabis industry. Being the first European company to enter into an agreement to sell CBD isolates to the Canadian market puts Farmako at a significant competitive advantage within the global market and also supports us in bridging the gap between cannabis and pharmaceuticals. With our unique Continuous Bacterial Cannabinoid Biosynthesis (CBCB) method using our patented Bacterium Zynmomonas Cannabinoides®, we are able to produce nature-identical cannabinoids very effectively and at very low costs on a large scale."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas podcasts

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Social Media

https://www.investorideas.com/About/

Contact Investorideas.com

800-665-0411

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories

Taking Care of Our #Pets: More #CBD Pet Products Coming to Market Drive Quality and Innovation (TSX: $WEED.TO) (NYSE: $CGC) (OTC: $LRSV) (OTC: $MJNA) (TSXV: $EAST.V)

Taking Care of Our #Pets: More #CBD Pet Products Coming to Market Drive Quality and Innovation (TSX: $WEED.TO) (NYSE: $CGC) (OTC: $LRSV) (OTC: $MJNA) (TSXV: $EAST.V)

Point Roberts WA, Delta BC – April 29, 2019 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how as the CBD pet market grows, more companies are putting in extra effort to create quality products and innovative technologies to ensure the best care possible for pets that are often considered family members by consumers.

Read this in full at https://www.investorideas.com/news/2019/cannabis/04292Stocks-CBDPetProducts.asp

A recent study published in The Pet Behavior Science Journal indicates that dogs with epilepsy can have less frequent seizures if treated using CBD oil.

While the study may have been small because it only followed three dogs over a period of two months while those dogs were treated with CBD oil, the research suggests that dogs respond to cannabis treatment in the same way that humans do.

One of the largest cannabis companies in the world, Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) and Sequential Brands Group, Inc. announced back in February that Martha Stewart had joined the Company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories, with a focus on pet products.

“I am delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living,” said Martha Stewart. “I’m especially looking forward to our first collaboration together, which will offer sensible products for people’s beloved pets.”

While we are still waiting with baited breath for more news and developments on Canopy’s pet product line, the company is not sitting idly by and is ensuring proper supply arrangements so as to be prepared to enter the market. More recently, the company announced its acquisition of AgriNextUSA, a hemp enterprise led by CEO Geoff Whaling, which has been at the forefront of hemp advocacy and building a vibrant hemp sector in the US. The acquisition will accelerate Canopy Growth’s entry into key American jurisdictions as regulations surrounding the full use of hemp as a crop begin to be implemented, thanks in part to the recently enacted 2018 US Farm Bill.

Hemp has the potential to disrupt several prominent industries: advanced materials, cosmetics, energy, fiber and textiles, food and protein production and the health and wellness sectors. In addition, hemp is a natural source of CBD, the non-intoxicating component of cannabis that can be used for health and wellness purposes, as well as pet products in jurisdictions where legally permitted.

LinkResPet, a subsidiary of Link Reservations Inc. (OTC: LRSV), a company providing CBD products especially tailored for pets, has recently announced that it is finalizing negotiations with a certified US-based CBD producer and fulfillment center and are currently in the final stage of negotiations.

Link Reservations Inc. is looking to establish itself in the US/North American market and has been communicating with various producers in order to find partners that meet their high standards, and has now found such a producer to advance on their first partnership.

Upon this arrangement being successfully completed and as the company explores retail opportunities, LRSV will be able to offer home delivery of its CBD pet products in the US and Canada. The company will also be in a position to supply products to brick & mortar pet retailers. This will be a key for future growth as the LinkResPet product line increases.

René Lauritsen, Link Reservations Inc. CEO commented: “This is a huge step for LRSV and our brand LinkResPet, and we are incredibly excited to be making advances in North America. We selected our new partner due to their high-grade CBD products and flexibility in production and delivery timeframes. We ensure our products undergo a rigorous process of quality control and testing, using the latest scientific methods that will confirm their quality and safety, which of course includes being free of bacteria, pesticides, mold, solvents, and other contaminants."

The producer is specialized in “SFE” technique (Supercritical Fluid Extraction), using state of the art equipment. “SFE/CO2 Extraction” is the most sophisticated method of professionally producing hemp oil extract, gently obtaining the extract and preserving many of the plant’s active molecules, while being environmentally friendly and sustainable. In this process, supercritical CO2 (carbon dioxide) gas is used in natural product extraction, offering the possibility to separate materials from each other selectively and with great care.

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States’ subsidiary, Phyto Animal Health recently announced the launch of its newest CBD pet product, HempBone Smoked Salmon Bites for cats.

HempBone Smoked Salmon Bites are artisanal star-shaped cat treats that are soft-baked and naturally-flavored to taste like smoked salmon and roasted seafood.

Small cats can enjoy three to four bites daily to help support overall wellness, while larger cats may require a larger serving. CBD has been studied extensively by top-veterinarians to promote cardiovascular function, support healthy joints, and promote neurological health and emotional behavior in pets.

"Our HempBone Bacon Apple Donuts have gained incredible popularity over the past year because of their natural allergen-free ingredients and palatable taste that dogs love," said Phyto Animal Health CEO, Ian Quinn. "We wanted to offer a safe and nutritious snack for cats as well so we created HempBone Smoked Salmon Bites. They are one-fourth of the CBD per serving size as the Bacon Apple Donuts and feature a more feline-focused flavor, better meeting the dosing needs and taste preferences of cats."

"There is currently an upward trend in the CBD pet supplement industry and for good reason," said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. "Phyto Animal Health leads this industry trend with premium quality, veterinarian-recommended CBD supplements in a variety of options that are customized to meet the needs of pets of many different sizes and species."

EastWest Bioscience Inc. (TSX-V: EAST) is also bringing new innovative products to market, having announced four additional products to its Natural Pet Science line, both in Canada and the US, with CBD included in the US destined products which will be marketed to CBD permitted jurisdictions.

Overshadowed by the significance of the CBD opportunity that the signing of the 2018 Farm Bill presented, in December 2018, The US Food and Drug Administration completed its evaluation of three generally recognized as safe (GRAS) notices for hemp seed-derived food ingredients. These ingredients being hulled hemp seed (GRN765), hemp seed protein powder (GRN771) and hemp seed oil (GRN778). These notices represent a real market opportunity for EastWest, which validates the Company's Canadian ‘product first' strategy.

EastWest's product development and sales strategy in the US will be similar to what it used to grow retail shelf space in Canada. Now that there is FDA approval for hemp-based foods, the Company's interesting and innovative hemp-based products with unique formulations and ingredients become attractive to distributors. As Eastwest's hemp products become established in retail stores and distribution networks it lowers the barrier of entry for the Company's CBD infused products.

"Hemp based products are still relatively new to US markets and distributors are always looking for innovative lines to sell. Our Hemp and Cricket pet treats on shelves in the US, even without CBD, represents an opportunity to increase revenues beyond what the Canadian market is capable of," states Rodney Gelineau, CEO of EastWest Bioscience Inc.

August 2018 figures from New Frontier Data found that hemp-derived pet supplies generated $13 million in 2017 and by 2022 it's expected that this number will reach upwards of $125 million.

Currently dogs and cats are the focus of the day as these are our most common North American pets, however as companies develop better quality products and increase distribution, we can expect to see horses and larger animals as beneficiaries of CBD as well, expanding the overall potential for the market. As more research comes out on the benefits of CBD for animals, we can look ahead to more companies entering the market, with companies having early entry in the sector gaining the lead.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

Follow us on Cannabis Social Media